Brazil's president warns of retaliation after Trump unveils 50 percent tariffs
In a statement posted to the social platform X, the Brazilian leader pushed back on 'inaccurate' claims of a U.S. trade deficit in its commercial relationship with Brazil, saying, 'Statistics from the U.S. government itself show a surplus of $410 billion in the trade of goods and services with Brazil over the past 15 years.'
'Therefore, any unilateral tariff increases will be addressed in accordance with Brazil's Economic Reciprocity Law,' Lula continued in the statement.
'Sovereignty, respect and the unwavering defense of the interests of the Brazilian people are the values that guide our relationship with the world,' he added.
The Economic Reciprocity Law was signed into law April 14, shortly after Trump announced his sweeping tariffs on numerous countries. The government cited Trump's tariffs as the impetus for the law.
The law authorizes the legislative branch to 'adopt countermeasures in the form of restrictions to the importation of goods and services or measures to suspend concessions in the areas of trade, investments, and obligations related to intellectual property rights, as well as measures to suspend other obligations foreseen in any of the country's trade agreements.'
Lula's statement comes after Trump announced Wednesday the 50 percent tariff on all goods from Brazil, citing the prosecution of former President Jair Bolsonaro over an alleged plot to remain in power after losing an election.
Trump, who has criticized Brazil's treatment of Bolsonaro in recent days, said in a letter to Lula that the new tariffs would take effect Aug. 1 and are 'due in part to Brazil's insidious attacks on Free Elections and the fundamental Free Speech Rights of Americans.'
Trump also cited Brazil's 'Tariff, and Non-Tariff, Policies and Trade Barriers.'
'The way that Brazil has treated former President Bolsonaro, a Highly Respected Leader throughout the World during his Term, including by the United States, is an international disgrace. This Trial should not be taking place. It is a Witch Hunt that should end IMMEDIATELY!' Trump wrote in the letter, which was posted to the president's Truth Social platform.
Lula, in his statement late Wednesday, defended the independence of his country's institutions, saying, 'Brazil is a sovereign nation with independent institutions and will not accept any form of tutelage.'
'The judicial proceedings against those responsible for planning the coup d'état fall exclusively under the jurisdiction of Brazil's Judicial Branch and, as such, are not subject to any interference or threats that could compromise the independence of national institutions,' Lula continued.
Lula also warned that digital companies must reject 'hateful content' and anti-democratic speech on their platforms if they want to continue operating in Brazil.
'In the context of digital platforms, Brazilian society rejects hateful content, racism, child pornography, scams, fraud, and speeches against human rights and democratic freedom,' he wrote.
'In Brazil, freedom of expression must not be confused with aggression or violent practices. All companies—whether domestic or foreign—must comply with Brazilian law in order to operate within our territory.'
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Solve the daily Crossword
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
20 minutes ago
- Yahoo
FTSE 100 LIVE: Markets calm as EU readies plan for no-deal trade scenario with US
The FTSE 100 (^FTSE) and European stocks were tepid on Monday morning, making small moves as the EU prepares a plan for a potential no-deal scenario in trade negotiations with the US. Leaders are set to meet early this week, according to a Bloomberg report, in order to formulate a plan ahead of the 1 August deadline set by president Donald Trump. As it stands, the US plans to implement tariffs on EU imports at 10% or higher, with fewer exemptions than once offered on the table, according to Bloomberg. Medical supplies, aviation and manufacturing equipment are among the items being haggled over. Negotiations are set to continue over the next fortnight. In previous weeks, the EU prepared a list of items imported from the US that it was prepared to slap higher levies on in order to strengthen its stance, while the US sent a letter saying the bloc would face a 30% tariff after the 1 August deadline, among other stipulations. London's premier index rose around 0.1% in early such as Antofagasta (ANTO.L), Anglo American (AAL.L) and Glencore (GLEN.L) led the index higher. Over in Germany, the DAX (^GDAXI) was flat. The CAC 40 (^FCHI) in Paris fell below the flatline. The pan-European STOXX 600 (^STOXX) also lacked direction, hovering slightly higher. Here's the US stock futures chart US stock futures higher as earnings season continues Our US team writes: US stock futures rose early Monday morning, as markets entered a critical week defined by megacap earnings and continued risk around President Trump's looming tariffs. S&P 500 (ES=F) futures climbed 0.2%, contracts on the Nasdaq 100 (NQ=F) gained 0.3%, while Dow Jones Industrial Average futures (YM=F) inched up 0.1%, reflecting a cautious tone after last week's record-setting rally in growth names. The Nasdaq advanced 1.5% last week, while the S&P 500 added 0.6%. The Dow lagged, finishing slightly negative. Investor focus is dominated by two topics for the upcoming week: policy clarity on trade and earnings from tech heavyweights. On Sunday, Commerce Secretary Howard Lutnick reaffirmed the White House's August 1 deadline for new tariffs, calling it a "hard stop" for compliance — before saying that he's looking at continued conversation beyond that date. Read more on Yahoo Finance Average UK house price down £5,000 The average price of a UK property coming to the market in July dropped by 1.2% to £373,709 in the largest monthly price drop at this time of year recorded in over 20 years of data, as new sellers lower their price expectations, according to Rightmove (RMV.L). According to the property site, this month's price drop of £4,531 comes as sellers lower expectations to catch buyers' attention amid a high supply of homes for sale. London, the country's largest regional market, leads the charge in price reductions with an overall drop of 1.5%, driven largely by Inner London, where prices fell by 2.1%. This market shift comes as sellers in the capital react to external factors, including changes to stamp duty and tax rules, while also trying to compete for the growing pool of potential buyers. Despite the price reductions, buyers are still active, with the number of sales agreed up 5% compared to this time last year. Furthermore, inquiries from potential buyers are 6% higher than in 2023, indicating continued demand. At the same time, affordability is improving for many buyers, helped by lower mortgage rates and rising wages. Read more on Yahoo Finance UK Good morning! Hello from London. Lucy Harley-McKeown here, gearing up to bring you the latest markets and economics headlines. This morning we have an update on UK house prices and also a trading statement from budget carrier Ryanair ( Trade tensions between the EU and US are also hotting up, so we'll be watching that, too. Let's get to it. Here's the US stock futures chart US stock futures higher as earnings season continues Our US team writes: US stock futures rose early Monday morning, as markets entered a critical week defined by megacap earnings and continued risk around President Trump's looming tariffs. S&P 500 (ES=F) futures climbed 0.2%, contracts on the Nasdaq 100 (NQ=F) gained 0.3%, while Dow Jones Industrial Average futures (YM=F) inched up 0.1%, reflecting a cautious tone after last week's record-setting rally in growth names. The Nasdaq advanced 1.5% last week, while the S&P 500 added 0.6%. The Dow lagged, finishing slightly negative. Investor focus is dominated by two topics for the upcoming week: policy clarity on trade and earnings from tech heavyweights. On Sunday, Commerce Secretary Howard Lutnick reaffirmed the White House's August 1 deadline for new tariffs, calling it a "hard stop" for compliance — before saying that he's looking at continued conversation beyond that date. Read more on Yahoo Finance Our US team writes: US stock futures rose early Monday morning, as markets entered a critical week defined by megacap earnings and continued risk around President Trump's looming tariffs. S&P 500 (ES=F) futures climbed 0.2%, contracts on the Nasdaq 100 (NQ=F) gained 0.3%, while Dow Jones Industrial Average futures (YM=F) inched up 0.1%, reflecting a cautious tone after last week's record-setting rally in growth names. The Nasdaq advanced 1.5% last week, while the S&P 500 added 0.6%. The Dow lagged, finishing slightly negative. Investor focus is dominated by two topics for the upcoming week: policy clarity on trade and earnings from tech heavyweights. On Sunday, Commerce Secretary Howard Lutnick reaffirmed the White House's August 1 deadline for new tariffs, calling it a "hard stop" for compliance — before saying that he's looking at continued conversation beyond that date. Read more on Yahoo Finance Average UK house price down £5,000 The average price of a UK property coming to the market in July dropped by 1.2% to £373,709 in the largest monthly price drop at this time of year recorded in over 20 years of data, as new sellers lower their price expectations, according to Rightmove (RMV.L). According to the property site, this month's price drop of £4,531 comes as sellers lower expectations to catch buyers' attention amid a high supply of homes for sale. London, the country's largest regional market, leads the charge in price reductions with an overall drop of 1.5%, driven largely by Inner London, where prices fell by 2.1%. This market shift comes as sellers in the capital react to external factors, including changes to stamp duty and tax rules, while also trying to compete for the growing pool of potential buyers. Despite the price reductions, buyers are still active, with the number of sales agreed up 5% compared to this time last year. Furthermore, inquiries from potential buyers are 6% higher than in 2023, indicating continued demand. At the same time, affordability is improving for many buyers, helped by lower mortgage rates and rising wages. Read more on Yahoo Finance UK The average price of a UK property coming to the market in July dropped by 1.2% to £373,709 in the largest monthly price drop at this time of year recorded in over 20 years of data, as new sellers lower their price expectations, according to Rightmove (RMV.L). According to the property site, this month's price drop of £4,531 comes as sellers lower expectations to catch buyers' attention amid a high supply of homes for sale. London, the country's largest regional market, leads the charge in price reductions with an overall drop of 1.5%, driven largely by Inner London, where prices fell by 2.1%. This market shift comes as sellers in the capital react to external factors, including changes to stamp duty and tax rules, while also trying to compete for the growing pool of potential buyers. Despite the price reductions, buyers are still active, with the number of sales agreed up 5% compared to this time last year. Furthermore, inquiries from potential buyers are 6% higher than in 2023, indicating continued demand. At the same time, affordability is improving for many buyers, helped by lower mortgage rates and rising wages. Read more on Yahoo Finance UK Good morning! Hello from London. Lucy Harley-McKeown here, gearing up to bring you the latest markets and economics headlines. This morning we have an update on UK house prices and also a trading statement from budget carrier Ryanair ( Trade tensions between the EU and US are also hotting up, so we'll be watching that, too. Let's get to it. Hello from London. Lucy Harley-McKeown here, gearing up to bring you the latest markets and economics headlines. This morning we have an update on UK house prices and also a trading statement from budget carrier Ryanair ( Trade tensions between the EU and US are also hotting up, so we'll be watching that, too. Let's get to it. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
20 minutes ago
- Yahoo
Government blocked streaming sites for public servants as a 'people management issue,' documents show
Although streaming services like Netflix and Amazon Prime Video weren't straining the government's network, federal officials decided to block them because they were perceived to be a "people management" issue, according to internal documents obtained by CBC News. Last December, the agency responsible for IT services, Shared Services Canada (SSC), blocked access to paid subscription streaming sites, including Netflix, Hulu, Apple TV+, Prime Video, Disney+ and Crave for 45 government departments and agencies. At the time, a spokesperson for SSC said "streaming services are not considered work tools and offer no business value for the Government of Canada." Documents released as part of an access to information request provide more insight on how the decision was made. In an October 2024 email, SSC president Scott Jones wrote to officials at the Treasury Board, saying he wanted to "raise a couple of issues," including the use of personal phones and streaming services among bureaucrats. He wrote about a recent meeting of deputy ministers, where they discussed the use of streaming services in federal buildings — and voiced his support to block them. "While streaming may ultimately impact the bandwidth available to the [Government of Canada], it is also more importantly a people management issue," he wrote. "In the current context and with public perception of the public service as it is … there is value in engaging [deputy ministers] on these issues and in committing SSC to take some action." Soon after, SSC moved to block the streaming services. This email and others were obtained via an access to information request made by Matt Malone, an assistant professor at the University of Ottawa, and shared with CBC News. Thousands of hours of streaming The request, which sought documents detailing the rationale behind the decision to ban streaming services on government networks, includes a report on traffic to the streaming sites in September 2024, broken down by department. The report shed a more fulsome light into how much streaming was being done on government networks, compared to the agency's official statement when the sites were banned. In a November 2024 statement, Shared Services Canada said that "network traffic monitoring shows limited traffic to these sites from government systems." The report on streaming is presented as a bar chart, showing total volume of streaming per terabyte (TB). The amount of data used depends on the quality of video streamed. As an example, Netflix offers four data usage settings — ranging from low quality to ultra-high definition. If users were streaming on standard definition, one terabyte would equal at least 1,000 hours. If they were streaming on high definition, then one terabyte equals at least 340 hours of video. The departments with the highest streaming included the Department of National Defence at over three terabytes, Public Services and Procurement Canada (PSPC) with almost three terabytes and the Privy Council Office with about 1.5 terabytes of volume per month. The report includes the "top 10" departments with highest traffic to streaming websites in September 2024, including Global Affairs Canada, the Department of Fisheries and Oceans (East), Innovation, Science and Economic Development Canada, Agriculture and Agri-Food Canada, Treasury Board Secretariat, Canada Revenue Agency and Crown-Indigenous Relations and Northern Affairs Canada. All of those departments reported about 0.75 TB of streaming volume in one month. Given the number of civil servants employed by the government, this volume is fairly minimal. For instance, PSPC alone has about 19,000 employees. Cybersecurity expert Eric Parent says the numbers presented just by volume of data don't paint a full picture. "The metric we're missing is how many users, how many users are actively on [streaming] and for how long," he said. The report also shows almost 10 TB of streaming done on the federal government's guest Wi-Fi. In a letter to colleagues, a director with SSC said the streaming numbers across the government could have been relatively low in part because they used a program that throttles the speed of streaming to prioritize different internet traffic on government networks.
Yahoo
20 minutes ago
- Yahoo
Cell‑Based Assays Report 2025: Key Market Drivers, Tech Trends & Competitive Landscape to 2030
The global cell-based assays market is set to grow from USD 17.84 billion in 2025 to USD 27.55 billion by 2030, marking a CAGR of 9.1%. This surge is fueled by the rising demand in drug discovery and increased R&D investments by the pharmaceutical and biotech industries. The prevalence of cancer is boosting the need for advanced therapies, while the growth of cell-based assays applications in chronic diseases and personalized medicine further propels market expansion. In 2024, the drug discovery and flow cytometry segments dominated the market. The US, with its strong healthcare infrastructure and biopharmaceutical industry, led the global market. Key companies in this sector include BD, Thermo Fisher Scientific, and Merck KGaA. Cell Based Assays Market Dublin, July 21, 2025 (GLOBE NEWSWIRE) -- The "Cell Based Assays Market by Offering (Consumables (Reagents, Assay Kits, Cell Lines, Microplates, Probes, Labels), Instruments & Software), Technology (Flow Cytometry, HTS), Application (Drug Discovery (Toxicity, PK/PD Studies)) - Global Forecast to 2030" has been added to global cell-based assays market is anticipated to expand from USD 17.84 billion in 2025 to USD 27.55 billion by 2030, achieving a compound annual growth rate (CAGR) of 9.1%. This growth is fueled by escalating demand in drug discovery and the increasing need for sophisticated therapies, particularly in oncology. An uptick in research and development investments from pharmaceutical and biotechnology firms is another catalyst propelling market expansion. Drug Discovery's Dominance in Applications Within the applications segment, drug discovery is poised to retain its prominence through 2024. It encompasses subcategories such as toxicity, pharmacokinetics, and pharmacodynamics studies. The segment's ascendancy is largely attributed to the burgeoning incidence of cancer, which heightens demand for novel therapies. Additionally, robust investments and the emergence of contract research organizations are significantly advancing drug discovery efforts. Flow Cytometry Leads Technological Innovations In 2024, the flow cytometry segment emerged as a leader within the technology category, driven by its pivotal role in providing comprehensive cell-based assay measurements. Enhanced adoption of cutting-edge technologies for cell analysis continues to bolster this sector, ensuring its sustained growth trajectory. Regional Insights and U.S. Market Leadership The U.S. held a commanding position in the North American market in 2024, attributed to its stature as the largest biopharmaceutical hub globally. This leadership is strengthened by significant research investments and a robust healthcare framework. The emphasis on developing advanced cell-based therapies is a key driver in response to rising cancer cases. Notable Market Players: BD (US) Thermo Fisher Scientific Inc. (US) Danaher Corporation (US) Merck KGaA (Germany) Agilent Technologies, Inc. (US) Lonza (Switzerland) Charles River Laboratories (US) Bio-Rad Laboratories, Inc. (US) REVVITY (US) Sartorius AG (Germany) And others Research Coverage and Market Insights: The report categorizes the cell-based assays market based on offerings, technology, applications, end users, and regions. It elucidates major drivers, restraints, opportunities, and challenges influencing market dynamics. Additionally, a comprehensive analysis of key industry players, including product launches, collaborations, and acquisitions, sheds light on the competitive landscape. Key Insights for Stakeholders: Drivers such as increasing demand for drug discovery, rising prevalence of cancer, and heightened R&D investments. Constraints involving high costs and licensing restrictions. Opportunities in chronic diseases and personalized medicine sectors. Competitive assessment of major players highlighting their strategies and market positioning. Key Attributes: Report Attribute Details No. of Pages 449 Forecast Period 2025 - 2030 Estimated Market Value (USD) in 2025 $17.84 Billion Forecasted Market Value (USD) by 2030 $27.55 Billion Compound Annual Growth Rate 9.1% Regions Covered Global Key Topics Covered: Market Dynamics Drivers Growing Demand For Drug Discovery & Development and Increasing Preference For Cell-Based Assays in Drug Discovery Government Support and Funding For Cell-Based Research Growing Efforts To Curtail Animal-Based Studies Rising Prevalence of Cancer Alliances To Accelerate Innovations in Drug Discovery Restraints High Cost of Instruments and Restrictions Imposed by Product End-User Licenses For Reagents Lack of Standardization of Protocols Used in Cell-Based Assays Opportunities Growing Applications of Cell-Based Assays in Chronic Diseases and Personalized Medicine Growth Opportunities in Emerging Economies Rising Adoption of AI in Drug Discovery and Cell Analysis Challenges Complexities in Assay Designs Shortage of Skilled Professionals Company Profiles Danaher Thermo Fisher Scientific Inc. Merck Kgaa BD Agilent Technologies, Inc. Lonza Eurofins Scientific Charles River Laboratories Bio-Rad Laboratories, Inc. Revvity Sartorius Ag Corning Incorporated Promega Corporation Cell Signaling Technology, Inc. Enzo Biochem Inc. Carna Biosciences, Inc. Intertek Group Plc Bico Cell Biolabs, Inc. Reaction Biology AAT Bioquest, Inc. Pestka Biomedical Laboratories, Inc. Neuromics BPS Bioscience, Inc. Bellbrook Labs Profacgen Bmg Labtech Gmbh Hanugen Therapeutics Altogen Labs Bioagilytix Labs For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Attachment Cell Based Assays Market CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
